-
1دورية أكاديمية
المؤلفون: Zhai, Q.L., Moes, D.J.A.R., Gelder, T. van, Lee, M. van der, Sanders, J.S., Bemelman, F.J., Fijter, J.W. de, Klein, K., Schwab, M., Swen, J.J.
المصدر: Clinical and Translational Science
وصف الملف: application/pdf
العلاقة: lumc-id: 187248670; https://hdl.handle.net/1887/3731547Test
-
2دورية أكاديمية
المؤلفون: Kamp, J., Zwart, T.C., Meziyerh, S., Boog, P.J.M. van der, Nijgh, E.E., Duin, K. van, Vries, A.P.J. de, Moes, D.J.A.R.
المصدر: Pharmaceutics
مصطلحات موضوعية: population pharmacokinetics, tacrolimus, prolonged release, kidney transplantation, elderly
وصف الملف: application/pdf
العلاقة: lumc-id: 186129029; https://hdl.handle.net/1887/3720907Test
-
3دورية أكاديمية
المؤلفون: Stoelinga, A.E.C., Tushuizen, M.E., Hout, W.B. van den, Girondo, M.D.M.R., Vries, E.S. de, Levens, A.D., Moes, D.J.A.R., Gevers, T.J.G., Meer, S. van der, Brouwer, H.T., Jonge, H.J.M. de, Boer, Y.S. de, Beuers, U.H.W., Meer, A.J. van der, Berg, A.P. van den, Guichelaar, M.M.J., Drenth, J.P.H., Hoek, B. van, Dutch Autoimmune Hepatitis Grp
المصدر: Trials
مصطلحات موضوعية: AIH, Autoimmune hepatitis, Autoimmune liver disease, Tacrolimus, Mycophenolate mofetil, Randomised controlled trials, Second-line treatment, Complete biochemical response
وصف الملف: application/pdf
العلاقة: lumc-id: 186231146; https://hdl.handle.net/1887/3720971Test
-
4دورية أكاديمية
المؤلفون: Groenland, S.L., van Eerden, R.A.G., Westerdijk, K., Meertens, M., Koolen, S.L.W., Moes, D.J.A.R., de Vries, N., Rosing, H., Otten, H., Vulink, A.J.E., Desar, I.M.E., Imholz, A.L.T., Gelderblom, H., van Erp, N.P., Beijnen, J.H., Mathijssen, R.H.J., Huitema, A.D.R., Steeghs, N.
المصدر: Annals of Oncology ; volume 33, issue 10, page 1071-1082 ; ISSN 0923-7534
مصطلحات موضوعية: Oncology, Hematology
الإتاحة: https://doi.org/10.1016/j.annonc.2022.06.010Test
https://api.elsevier.com/content/article/PII:S0923753422017392?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753422017392?httpAccept=text/plainTest -
5
المؤلفون: Lemaitre, F., Budde, K., Gelder, T. van, Bergan, S., Lawson, R., Noceti, O., Venkataramanan, R., Elens, L., Moes, D.J.A.R., Hesselink, D.A., Pawinski, T., Johnson-Davis, K.L., Winter, B.C.M. de, Pattanaik, S., Brunet, M., Masuda, S., Langman, L.J.
المساهمون: Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Leiden University Medical Center (LUMC), University of Oslo (UiO), Ciblage individuel et prévention des risques de traitements immunosupresseurs et de la transplantation (IPPRITT), CHU Limoges-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST), Université de Limoges (UNILIM)-Université de Limoges (UNILIM), National Center for Liver Transplantation [Montevideo, Uruguay], University of Pittsburgh (PITT), Pennsylvania Commonwealth System of Higher Education (PCSHE), Université Catholique de Louvain = Catholic University of Louvain (UCL), Erasmus University Medical Center [Rotterdam] (Erasmus MC), Medical University of Warsaw - Poland, University of Utah, Post Graduate Institute of Medical Education and Research [Chandigarh, India] (PGIMER), University of Barcelona, Dokkyo Medical University, Mayo Clinic [Rochester], None, Jonchère, Laurent, Universiteit Leiden, UCL - SSS/LDRI - Louvain Drug Research Institute
المصدر: Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, 2022, ⟨10.1097/FTD.0000000000001014⟩
Therapeutic Drug Monitoring, 45(2), 191-199. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic Drug Monitoring, Vol. 45, no.2, p. 191-199 (2023)مصطلحات موضوعية: Pharmacology, Transplantation, mTOR inhibitors, [SDV]Life Sciences [q-bio], [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences, Tacrolimus, [SDV] Life Sciences [q-bio], [SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciences, Calcineurin inhibitors, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Drug-drug interactions, Pharmacology (medical)
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43bcc75bc32e1b83e785c720267a1011Test
https://doi.org/10.1097/ftd.0000000000001014Test -
6
المؤلفون: Straatmijer, T., Biemans, V.B.C., Moes, D.J.A.R., Hoentjen, F., ter Heine, R., Maljaars, P.W.J., Theeuwen, R., Pierik, M., Duijvestein, M., van der Meulen-de Jong, A.E.E.
المساهمون: Interne Geneeskunde, MUMC+: MA Maag Darm Lever (9), RS: NUTRIM - R2 - Liver and digestive health
المصدر: Digestive Diseases and Sciences, 68, 2647-2657
Digestive Diseases and Sciences, 68, 6, pp. 2647-2657
Digestive Diseases and Sciences, 68(6), 2647-2657. Springerمصطلحات موضوعية: Crohn's disease, All institutes and research themes of the Radboud University Medical Center, lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], Physiology, Gastroenterology, Other Research Radboud Institute for Molecular Life Sciences [Radboudumc 0], Ustekinumab, Pharmacokinetics, SUBCUTANEOUS USTEKINUMAB, THERAPY, Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5], Inflammatory bowel disease, SERUM
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::732a3d5a6d22e010f853cba11caaef78Test
https://doi.org/10.1007/s10620-023-07822-7Test -
7دورية أكاديميةChloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals
المؤلفون: Brüggemann, R.J., Moes, D.J.A.R., van Rhee, K.P., van 't Veer, N.E., Koch, B.C.P., van Rossum, M., Windsant - van den Tweel, A. Vermeulen, Reijers, M.H.E., van Kimmenade, R.R.J., Rahamat-Langedoen, J.C., Rettig, T.C.D., van Raalte, R., van Paassen, J., Polderman, F.N., van der Linden, P.D., Frenzel, T., de Mast, Q., Burger, D.M., Schouten, J., van de Veerdonk, F.L., Pickkers, P., ter Heine, R.
المصدر: International Journal of Antimicrobial Agents ; volume 57, issue 3, page 106293 ; ISSN 0924-8579
مصطلحات موضوعية: Pharmacology (medical), Infectious Diseases, Microbiology (medical), General Medicine
الإتاحة: https://doi.org/10.1016/j.ijantimicag.2021.106293Test
https://api.elsevier.com/content/article/PII:S0924857921000236?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0924857921000236?httpAccept=text/plainTest -
8
المؤلفون: Meziyerh, S., Bouwmans, P., Gelder, T. van, Helm, D. van der, Messchendorp, L., Boog, P.J.M. van der, Fijter, J.W. de, Moes, D.J.A.R., Vries, A.P.J. de, RECOVAC Collaborators
المساهمون: Interne Geneeskunde, RS: Carim - V02 Hypertension and target organ damage
المصدر: Clinical Pharmacology & Therapeutics. WILEY
Clinical Pharmacology & Therapeutics
Clinical Pharmacology & Therapeutics. Wileyمصطلحات موضوعية: Pharmacology, Pharmacology (medical)
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd9745103e347bef12e5667d7e7d55feTest
https://doi.org/10.1002/cpt.2872Test -
9دورية أكاديمية
المؤلفون: Achini-Gutzwiller, F.R., Schilham, M.W., Asmuth, E.G.J. von, Jansen-Hoogendijk, A.M., Zijde, C.M. van der, Tol, M.J.D. van, Bredius, R.G.M., Gungor, T., Lankester, A.C., Moes, D.J.A.R.
المصدر: Blood Advances
وصف الملف: application/pdf
العلاقة: https://ashpublications.org/bloodadvances/article/7/16/4462/496180/Exposure-response-analysis-of-alemtuzumab-inTest; lumc-id: 185795624; https://hdl.handle.net/1887/3762868Test
الإتاحة: https://doi.org/10.1182/bloodadvances.2022009051Test
https://hdl.handle.net/1887/3762868Test
https://ashpublications.org/bloodadvances/article/7/16/4462/496180/Exposure-response-analysis-of-alemtuzumab-inTest -
10دورية أكاديمية
المؤلفون: Swets, M.C., Moss, R.J., Kor, F., Hilarius, D., Moes, D.J.A.R., Berkhout, W.E., Toorn, L.M. van den, Oever, N.C.G. van den, Valk, R. de, Rosendaal, F.R., Hunfeld, N., Groeneveld, G.H., Boer, M.G.J. de
المصدر: International Journal of Infectious Diseases
مصطلحات موضوعية: IL-6 inhibitor, COVID-19, SARS-CoV-2, Tocilizumab, Sarilumab
وصف الملف: application/pdf
العلاقة: https://www.sciencedirect.com/science/article/pii/S1201971223000413?via%3DihubTest; lumc-id: 184708427; https://hdl.handle.net/1887/3677617Test
الإتاحة: https://doi.org/10.1016/j.ijid.2023.01.041Test
https://hdl.handle.net/1887/3677617Test
https://www.sciencedirect.com/science/article/pii/S1201971223000413?via%3DihubTest